GURU.Markets stock price, segment price, and overall market index valuation
The company's share price MODD
Shares of Modular Medical, a company developing insulin pumps, are a venture bet on its product. Their price reflects not current revenues, but investors' faith in the device's potential, dependence on FDA approval, and competition in the diabetes technology market.
Share prices of companies in the market segment - Specialized medical equipment
Modular Medical is developing a next-generation insulin pump, aiming to make it simpler and more accessible for people with diabetes. We've classified it as "Specialized Medical Equipment." The chart below shows how investors evaluate new diabetes treatment technologies.
Broad Market Index - GURU.Markets
Modular Medical is developing a next-generation insulin pump, aiming to make it simpler and more accessible for people with diabetes. As part of the GURU.Markets index, it represents the diabetes technology sector. The chart below represents the entire market. See how this company's stock compares to the overall trend.
Change in the price of a company, segment, and market as a whole per day
MODD - Daily change in the company's share price MODD
For Modular Medical, Inc., a developer of insulin pumps, daily volatility reflects sensitivity to news about clinical trials and FDA approvals. This metric is an important element for analyzing companies in the diabetes care sector.
Daily change in the price of a set of shares in a market segment - Specialized medical equipment
Modular Medical, Inc. is a medical device company. This chart illustrates the high volatility of the MedTech industry. Comparing it to MODD, which focuses on insulin pumps, helps us understand how its innovative products contribute to its volatility.
Daily change in the price of a broad market stock, index - GURU.Markets
Modular Medical is developing an innovative insulin pump, aiming to make it more accessible and easier to use. This medtech company's shares are responding to clinical advances and regulatory decisions, contributing to the overall volatility in the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization MODD
Modular Medical, Inc.'s year-to-date performance is a story about the development of a new insulin pump. Its 12-month market cap depends entirely on progress toward FDA approval. The success of its simpler, more affordable pump could allow it to carve out a niche in the vast and highly competitive diabetes treatment market.
Annual dynamics of market capitalization of the market segment - Specialized medical equipment
Modular Medical is developing an innovative insulin pump designed for ease of use and affordability. Its success depends on approval and its ability to compete with the giants. Its performance relative to the industry will reveal the market's belief in its disruptive potential for the diabetes market.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
Modular Medical, developing insulin pumps, is a speculative bet on the future of medicine. Its stock price isn't tied to the economy, but rather to its technological breakthroughs and ability to compete with the giants. The chart tells the story of investors' faith that its innovation will become the new standard.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization MODD
Modular Medical is developing an insulin pump. As it enters the development and approval stages, its monthly pricing is dependent on news. Progress in clinical trials and interactions with the FDA are the key events shaping investor expectations and the product's schedule.
Monthly dynamics of market capitalization of the market segment - Specialized medical equipment
Modular Medical develops innovative insulin pumps. The diabetes medical device sector is vast and constantly evolving. The chart below shows how investors assessed the prospects of new players seeking to offer simpler and more accessible solutions for millions of patients, as well as general trends in this field.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Modular Medical is developing an innovative insulin pump. It's a medical device company in the development stage, and its stock is a speculative bet on the success of its product in the vast diabetes device market. Its performance will be determined by news of clinical trials and regulatory approval.
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization MODD
Modular Medical is developing a new generation of insulin pumps. The company's weekly stock price is highly volatile and depends on key developments, including news of FDA approval, clinical trial results, and competition in the high-tech diabetes device market.
Weekly dynamics of market capitalization of the market segment - Specialized medical equipment
Modular Medical is developing a new generation of insulin pumps. The company's weekly stock price is highly volatile and depends on key developments, including news of FDA approval, clinical trial results, and competition in the high-tech diabetes device market.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
Shares of Modular Medical, a medical technology company, live in a world of their own. Their performance is driven by news of regulatory approvals. A chart comparing the stock to the S&P 500 clearly demonstrates how the stock can rise or fall on company-specific events, completely ignoring the market.
Market capitalization of the company, segment and market as a whole
MODD - Market capitalization of the company MODD
Modular Medical's market capitalization tells the story of an attempt to create a simpler, more affordable insulin pump. The chart of this company, founded by an industry veteran, reflects investors' hopes that its product will capture market share in a market dominated by a few large players. It's a visualization of the bet on simplification in medical technology.
MODD - Share of the company's market capitalization MODD within the market segment - Specialized medical equipment
Modular Medical is developing new insulin pumps, aiming to make them simpler and more accessible. Its market capitalization reflects its product's potential in the vast diabetes treatment market. The chart below shows how investors assess its chances of competing with established leaders.
Market capitalization of the market segment - Specialized medical equipment
Modular Medical is developing a new type of insulin pump, aiming to make it simpler and more accessible to a wider range of diabetics. The chart below shows the overall market capitalization of the specialized medical equipment sector, reflecting the vast diabetes treatment market and the need for more convenient devices.
Market capitalization of all companies included in a broad market index - GURU.Markets
This shows a new approach to diabetes treatment. Modular Medical is developing a simple and affordable insulin pump. Its line on the graph represents the company's bet that it can offer a cheaper and more convenient solution for millions of patients who currently use syringes or more expensive devices.
Book value capitalization of the company, segment and market as a whole
MODD - Book value capitalization of the company MODD
Modular Medical's book value is its intellectual property for a new, easier-to-use insulin pump and the financial reserves needed to bring it to market. This represents its medical and technological capital. The chart shows how the company accumulates and expends resources to complete regulatory procedures and prepare for commercialization.
MODD - Share of the company's book capitalization MODD within the market segment - Specialized medical equipment
Modular Medical develops new, easier-to-use insulin pumps. Its assets include R&D centers and manufacturing facilities for assembling these medical devices. The chart shows the company's share of the physical infrastructure required to manufacture diabetes management products.
Market segment balance sheet capitalization - Specialized medical equipment
Developing medical devices, as the BCap_Seg chart shows, is capital-intensive. Modular Medical, when creating its insulin pumps, must invest in high-precision manufacturing and R&D. The chart illustrates the backdrop against which the physical product must be flawless.
Book value of all companies included in the broad market index - GURU.Markets
Modular Medical's assets are capital invested in the development and production of a new generation of insulin pumps. The book value reflects the financial and material basis for creating simpler and more accessible medical devices that improve the lives of people with diabetes.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - MODD
Modular Medical is developing new insulin pumps. This is a medical device where patents and design are everything. The company's book value is small. Market capitalization is an estimate of its chances of competing with the giants in the diabetes treatment market. The MvsBCap chart will depend entirely on product news, approval, and market acceptance.
Market to book capitalization ratio in a market segment - Specialized medical equipment
Modular Medical is developing new insulin pumps. As a medical device company, its value lies in innovative product design and patents. The chart shows how the market perceives its potential to compete in the diabetes treatment market.
Market to book capitalization ratio for the market as a whole
Modular Medical is developing new, easier-to-use insulin pumps. Its goal is to make this technology accessible to more people with diabetes. The company's market valuation reflects its product's potential to transform the market and improve the lives of millions, not the cost of its assembly lines.
Debts of the company, segment and market as a whole
MODD - Company debts MODD
Modular Medical, a company developing a new type of insulin pump, is devoting all its capital to completing development, clinical trials, and obtaining FDA approval. Developing a complex medical device is a capital-intensive process with high regulatory barriers. This chart shows how the company is funding its path to entering the diabetes technology market.
Market segment debts - Specialized medical equipment
Modular Medical is developing new, easier-to-use insulin pumps. Bringing a new medical device to market, especially in a competitive field like diabetes, requires significant capital for manufacturing, clinical trials, and marketing. The chart shows how the company is funding its path to commercialization.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio MODD
Modular Medical develops innovative insulin pumps, competing in the medical device market. This chart shows the company's reliance on debt to finance its development and market entry. The high debt is a bet that their product will prove popular and displace established players.
Market segment debt to market segment book capitalization - Specialized medical equipment
Modular Medical is developing next-generation insulin pumps. This chart shows the overall debt burden in the diabetes medical device sector. It helps understand how the company is financing its entry into a highly competitive market dominated by large players, and how its financial strategy aligns with the need for continuous innovation.
Debt to book value of all companies in the market
Modular Medical is developing an innovative insulin pump, aiming to make it more accessible and easier to use. The overall debt burden in the economy, shown in this chart, impacts the medical device market. The ability of patients and healthcare systems to pay determines how quickly new devices can be introduced to the market.
P/E of the company, segment and market as a whole
P/E - MODD
For Modular Medical, a company developing insulin pumps, this chart shows the market's valuation of its diabetes treatment innovations. The trend reflects investors' hopes that its simpler, more affordable product will capture market share in a market dominated by large players and improve patients' lives.
P/E of the market segment - Specialized medical equipment
This chart shows the average P/E valuation for the medical devices sector, where Modular Medical develops insulin pumps. The industry's high valuation reflects a belief in innovation. This metric serves as a benchmark for understanding how the market views Modular Medical's potential in the competitive diabetes treatment market.
P/E of the market as a whole
Modular Medical is developing a new generation of insulin pumps, aiming to make them simpler and more accessible for people with diabetes. The company's success depends on regulatory approval and its ability to compete with market giants. This chart shows the sentiment in the medtech sector. It helps understand how the market assesses Modular Medical's chances of carving out a niche in the vast diabetes treatment market.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company MODD
Modular Medical is developing a new type of insulin pump aimed at ease of use and accessibility for a wide range of diabetes patients. The company's growth depends on the approval and adoption of its product. This chart reflects analysts' confidence in the company's ability to successfully compete in the established insulin pump market.
Future (projected) P/E of the market segment - Specialized medical equipment
Modular Medical is developing a next-generation insulin pump, aiming to make it simpler and more accessible for people with diabetes. This chart shows how its future revenue expectations compare to the industry average. Does the market believe its product can compete with established market leaders?
Future (projected) P/E of the market as a whole
Modular Medical develops innovative insulin pumps, aiming to make them more accessible. As a medical technology company, its growth depends on the introduction of new products. This chart, reflecting investors' overall risk appetite, impacts the company's ability to fund production and marketing. Market optimism favors such innovators.
Profit of the company, segment and market as a whole
Company profit MODD
Modular Medical, Inc. is developing a next-generation insulin pump, aiming to make it simpler and more accessible for people with diabetes. The company's profitability is a future goal, contingent on regulatory approval and successful market launch. This chart illustrates the investment in developing a medical device that could change the lives of millions.
Profit of companies in the market segment - Specialized medical equipment
Modular Medical is developing a new generation of insulin pumps, aiming to make them simpler and more accessible for people with diabetes. This chart shows the overall profitability of the diabetes medical device sector, a huge and growing market where innovations focused on user convenience can quickly gain traction.
Overall market profit
Modular Medical is developing new, easier-to-use insulin pumps. Demand for medical devices for diabetes is growing, but adoption of new technologies depends on their cost and insurance coverage. The overall economic situation, reflected in the chart, influences the generosity of insurance plans.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company MODD
Modular Medical is developing a new type of insulin pump aimed at ease of use and accessibility for a wide range of diabetes patients. This chart shows how analysts assess the company's chances of carving out a niche in the highly competitive diabetes treatment device market and achieving profitability.
Future (predicted) profit of companies in the market segment - Specialized medical equipment
Modular Medical is developing a new generation of insulin pumps, aiming to make them simpler and more accessible for people with diabetes. The company is targeting a mass market that is currently unserved by existing complex devices. This chart shows profitability forecasts for the medical device sector, providing context for assessing the potential for simplifying diabetes treatment technologies.
Future (predicted) profit of the market as a whole
Modular Medical is developing new, easier-to-use insulin pumps. The company's success depends on its ability to compete with market giants and on the purchasing power of its patients. The overall corporate profit forecast, shown in this chart, indirectly reflects the state of the economy, which affects insurance coverage and the income of potential users.
P/S of the company, segment and market as a whole
P/S - MODD
Modular Medical is developing new insulin pumps. For a medical technology company in the commercialization stage, this chart is critical. It shows how the market views its sales potential and its ability to compete with established players in the diabetes treatment market.
P/S market segment - Specialized medical equipment
Modular Medical, Inc. is developing a next-generation insulin pump, aiming to make it simpler and more accessible for people with diabetes. This chart shows the average revenue estimate for the medical device sector. It helps gauge how highly investors perceive the company's product's potential to transform the diabetes treatment market.
P/S of the market as a whole
Modular Medical is developing a new generation of insulin pumps, aiming to make them simpler and more accessible for people with diabetes. Their success depends on securing approvals and competing with market giants. This chart, showing the valuations of companies based on actual revenue, serves as a contrast, highlighting investor expectations for innovation in medical devices.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company MODD
Modular Medical is developing a next-generation insulin pump, aiming to make this technology simpler and more accessible for people with diabetes. This chart shows how the market estimates future sales of its device. The assessment is based on the company's potential to capture market share in diabetes management by offering a more convenient solution.
Future (projected) P/S of the market segment - Specialized medical equipment
Modular Medical is developing an innovative, easy-to-use insulin pump for people with diabetes. The company strives to make cutting-edge technology accessible to a wider range of patients. This chart shows how the market views its product compared to the specialized medical equipment sector.
Future (projected) P/S of the market as a whole
Modular Medical is developing a new generation of insulin pumps, aiming to make them simpler and more accessible. This graph, reflecting overall healthcare spending expectations, is important for the company's future. Economic stability allows healthcare systems and patients to consider new, more convenient diabetes management technologies, creating a market for Modular Medical's products.
Sales of the company, segment and market as a whole
Company sales MODD
Modular Medical is developing an innovative insulin pump, aiming to make it simpler and more accessible for people with diabetes. This chart reflects funding during the development stage, which may include grants or funding. It shows the investment in the creation of a new medical device that could improve the lives of millions of patients.
Sales of companies in the market segment - Specialized medical equipment
Modular Medical, Inc. is developing an innovative, easy-to-use insulin delivery system aimed at the mass market of diabetes patients. While still in the development stage, its business can be roughly segmented by potential product lines. This graph may reflect revenue from early partnerships or grants related to one of its technology areas.
Overall market sales
Modular Medical develops innovative insulin pumps, aiming to make them simpler and more accessible for people with diabetes. Demand for its products is driven not by economic cycles, but by the growing prevalence of diabetes and the need for better devices to manage this condition. The company operates in a vast and socially significant healthcare market.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company MODD
Modular Medical is developing a new insulin pump, which it claims will be easier to use and more affordable than existing products. Future sales projections are based on expectations of regulatory approval and the company's ability to compete with established leaders in the diabetes treatment market.
Future (projected) sales of companies in the market segment - Specialized medical equipment
Modular Medical is developing a new generation of insulin pumps, aiming to make them simpler and more accessible. This chart reflects expectations for the entire diabetes treatment device sector. It helps assess the growth of the glucose monitoring device market and the demand analysts predict for convenient patient technologies.
Future (projected) sales of the market as a whole
Modular Medical is developing new insulin pumps. Demand for its products will depend on its ability to compete in the diabetes device market and healthcare budgets. This chart of overall sales forecasts reflects the economic situation affecting patient access to advanced medical technologies.
Marginality of the company, segment and market as a whole
Company marginality MODD
Modular Medical is developing an innovative insulin pump, aiming to make it simpler and more accessible to users. While in the development and approval stages, the company is actively investing in R&D. This chart shows its current financial trajectory, with engineering and clinical trial costs forming the foundation for future commercialization.
Market segment marginality - Specialized medical equipment
Modular Medical is developing a next-generation insulin pump designed for ease of use. In the diabetes medical device industry, profitability depends on product innovation and manufacturing efficiency. The chart shows how their operating model compares to established market leaders.
Market marginality as a whole
Modular Medical is developing an innovative insulin pump, aiming to make it simpler and more accessible for people with diabetes. The company's profitability will depend on the successful launch of the product. This chart shows the profitability of established companies, but for MODD, the ability to offer a more convenient solution to millions of patients is key to future success.
Employees in the company, segment and market as a whole
Number of employees in the company MODD
Modular Medical is creating a new generation of easy-to-use insulin pumps. This graph shows the team of engineers and clinical specialists. The growth of this team will be a key indicator of progress toward FDA approval and the commercial launch of a product that could make life easier for people with diabetes.
Share of the company's employees MODD within the market segment - Specialized medical equipment
Modular Medical is developing new, easier-to-use insulin pumps for people with diabetes. Creating a user-focused medical device requires a team of engineers and designers. This metric reflects the company's investment in improving the quality of life for millions of patients.
Number of employees in the market segment - Specialized medical equipment
Modular Medical is developing a new type of insulin pump focused on ease of use. This chart shows employment in the specialized medical equipment sector. The growing number of engineers and clinicians working in diabetes care indicates a high demand for more convenient and accessible devices for millions of patients, a target market for Modular Medical.
Number of employees in the market as a whole
Modular Medical is developing new insulin pumps. Demand for diabetes treatment devices is driven by medical needs and is not affected by economic cycles. This chart shows overall occupancy, but for Modular Medical, it's more important to offer patients a more convenient and affordable solution than competitors.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company MODD (MODD)
Modular Medical, Inc. is developing next-generation insulin pumps. In the medical device industry, a high market capitalization per employee speaks to the value of intellectual property. This chart shows that investors highly value the potential of a product created by a small team of engineers to transform the diabetes treatment market.
Market capitalization per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Modular Medical develops innovative insulin pumps, striving to make them more accessible and easier to use. In the medical device industry, this metric reflects the market's assessment of their technology and potential to transform the diabetes device market. It's a measure of the value of the team working on a breakthrough product.
Market capitalization per employee (in thousands of dollars) for the overall market
Modular Medical is developing a next-generation insulin pump, aiming to make it simpler and more accessible to users. This is an innovation in the vast diabetes treatment market. The chart reflects the potential value the market places on the team's work, which aims to improve the lives of millions of people.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company MODD (MODD)
Modular Medical is developing an innovative, easy-to-use insulin pump designed for the mass market of type 2 diabetics. Currently, it is an R&D company preparing for commercialization. This graph (likely negative) shows how much capital is being invested in each engineer and employee to bring this medical device to a competitive market.
Profit per employee (in thousands of dollars) in the market segment - Specialized medical equipment
Modular Medical develops and manufactures innovative insulin pumps, striving to make them more accessible. For a medical device company, this metric reflects the efficiency of the entire product cycle, from development to sales. It allows one to assess how productive their team is in product development and sales compared to competitors in the market.
Profit per employee (in thousands of dollars) for the market as a whole
Modular Medical (MODD) develops insulin pumps. It's a MedTech company at the intersection of R&D and commercialization. This metric, likely negative, reflects the "cost" of its team of engineers and doctors. It tells investors the amount of capital the company is burning through on staff to advance its product into the competitive diabetes market.
Sales to employees of the company, segment and market as a whole
Sales per company employee MODD (MODD)
Modular Medical is developing a new generation of insulin pumps. While it's in the development and approval stages, it may not generate any revenue. This timeline will ultimately determine whether its innovative product can gain market share in the competitive diabetes treatment market.
Sales per employee in the market segment - Specialized medical equipment
Modular Medical is developing new, simpler, and more affordable insulin pumps for people with diabetes. They aim to bring this technology to the masses. This chart compares Modular's revenue per employee to the industry average. It helps assess how commercially successful their approach to simplifying medical equipment is compared to competitors.
Sales per employee for the market as a whole
Modular Medical (MODD) is developing a new, simpler, and more affordable insulin pump. It's a MedTech company targeting the vast diabetes market. At the pre-commercialization (FDA approval) stage, the company has no revenue. This chart will show $0. This will become key when the company begins mass sales of its device.
Short shares by company, segment and market as a whole
Shares shorted by company MODD (MODD)
Modular Medical (MODD) is developing a new, simpler insulin pump. The diabetes market is vast, but it's dominated by giants (Medtronic, Insulet). This chart shows the number of investors who doubt the small company has the resources to displace the market leaders and gain insurance approval.
Shares shorted by market segment - Specialized medical equipment
Modular Medical is developing an innovative insulin pump, aiming to make it simpler and more accessible for people with diabetes. It's a highly competitive market dominated by giants. This chart shows the odds against the diabetes equipment sector, reflecting investor skepticism that a new player will be able to displace the established leaders.
Shares shorted by the overall market
Modular Medical (MODD) is an R&D company developing insulin pumps. It's a speculative bet. When this market fear indicator rises, investors' risk appetite plummets. They sell off unprofitable stocks like MODD, whose fate depends on R&D.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator MODD (MODD)
Modular Medical is developing new, easier-to-use insulin pumps for diabetics. It's a competitive market dominated by giants. This indicator tracks speculative interest in their technology, showing "overheated" (above 70) on news of FDA approval or "oversold" (below 30) pending funding.
RSI 14 Market Segment - Specialized medical equipment
Modular Medical is developing an innovative insulin pump designed to be easier to use and more affordable than existing devices. This metric measures the overall momentum in the diabetes technology sector and helps determine whether the entire segment is overheated by expectations.
RSI 14 for the overall market
Modular Medical, a medical equipment developer, is pure R&D. This chart is its lifeline. During periods of euphoria, investors are willing to fund the "future of medicine." In moments of panic, they flee unprofitable speculation, and MODD risks running out of funds for its breakthrough, but expensive, research.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast MODD (MODD)
Modular Medical is developing a new, simpler and more affordable insulin pump (MODD-1) for people with diabetes. This chart shows the average target price. Analysts' forecasts are based on success in obtaining FDA approval and the company's ability to compete with dominant players in the insulin pump market.
The difference between the consensus estimate and the actual stock price MODD (MODD)
Modular Medical is a medical technology company developing a simple and affordable insulin pump designed to compete with complex systems. This chart shows the difference between the market valuation and the consensus forecast. It reveals whether experts believe this "simplified" model can capture market share in the diabetes care market.
Analyst consensus forecast for stock prices by market segment - Specialized medical equipment
Modular Medical is developing a new, simpler, and less expensive insulin pump for diabetes patients. This chart shows general expectations for the specialized medical equipment sector. It reflects whether experts believe the market for "affordable" diabetes devices will grow or whether they consider it overcrowded.
Analysts' consensus forecast for the overall market share price
Modular Medical is developing a next-generation insulin pump designed to be simpler and more accessible for diabetes patients. This chart shows the overall risk appetite. For MODD, a development-stage company competing with giants, overall market optimism (risk appetite) is critical to raising capital for development completion and commercialization.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index MODD
Modular Medical is an insulin pump for the masses. They are developing a (not yet approved) pump that is designed to be simple and affordable (rather than high-tech) to make this technology accessible to patients with type 2 diabetes. This chart is a pure indicator of their R&D. It reflects their (very long) path to FDA approval and their risky bet on simplicity.
AKIMA Market Segment Index - Specialized medical equipment
Modular Medical (MODD) is developing an innovative insulin pump, aiming to make it simpler, more affordable, and more convenient to use for people with diabetes. The chart shows the average index for the segment, helping investors assess how MODD's product stacks up against strong competitors in the specialized medical equipment sector for diabetes treatment.
The AKIM Index for the overall market
Modular Medical is developing a simple and affordable insulin pump for people with diabetes. This chart, which reflects the market average, provides context. It helps us understand how this company, focused on expanding the pump market, fits into the overall macroeconomic trends in MedTech.